- Email: [email protected]
Surgery For Constipation In Patients With Prior Spinal Cord Injury: The Department Of Veterans Affairs Experience
176
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
5.10. An Urban-Rural Blight? Choledocholithiasis Presentation And Treatment. J. Shelton, K. Kummerow, S. Phillips, M. R. Griffin, M. D. Holzman, W. Nealon, C. Pinson, B. K. Poulose; Vanderbilt University Medical Center, Nashville, TN
5.11. Ethnicity And Insurance Status Affect Health Disparities In Patients With Gallstone Disease. J. J. Freeman, L. A. Boomer, A. Shenoy, D. Fursevich, A. Feliz; University of Nevada School of Medicine, Department of Surgery, Las Vegas, Nevada
5.12. The Impact of Diagnosis and Symptoms on Quality of Life of Patients with Colorectal Disease. What Matters Most? V. Advani, M. Thomas, J. Patton, M. L. Boehler, C. J. Schwind, J. Rakinic, I. Hassan; Southern Illinois University School of Medicine, Springfield, IL
5.13. The Role Of Minimal Invasive Surgery In Uncomplicated Diverticulitis. R. Pendlimari, M. Huebner, D. W. Larson, R. R. Cima; Mayo Clinic, Rochester, Minnesota
5.14. The Role Of Minimal Invasive Surgery In Complicated Diverticulitis. R. Pendlimari, M. Huebner, R. R. Cima, D. W. Larson; Mayo Clinic, Rochester, Minnesota
5.15. Factors That Affect Mortality Following Colectomy. D. A. Klima, R. A. Brintzenhoff, A. Neal, B. T. Heniford, G. Mostafa; Carolinas Laparoscopic and Advanced Surgery Program, Charlotte, NC
5.16. Incidence Of Bowel Obstruction Following Restorative Proctocolectomy: Increased After A Laparoscopic Approach? S. Dolejs, G. Kennedy, C. P. Heise; University of Wisconsin School of Medicine and Public Health, Madison, WI
5.17. Surgery For Constipation In Patients With Prior Spinal Cord Injury: The Department Of Veterans Affairs Experience. J. R. West, S. A. Mohiuddin, W. R. Hand, K. S. Virgo, E. M. Grossman, F. E. Johnson; Saint Louis University School of Medicine, Saint Louis, MO
ONCOLOGY 1: ONCOLOGY BASIC SCIENCE: PROGNOSTICS & THERAPEUTICS 6.1. Attempts To Enhance Gemcitabine Effects By Antiangiogenic Therapies In Pancreatic Cancer. N. Awasthi, M. A. Schwarz, R. E. Schwarz; University of Texas Southwestern Medical Center, Dallas, TX
6.2. Monotherapy with a selective EGFR inhibitor, gefitinib, fails to suppress vascular proliferation and tumor growth in a murine model of Ewing’s sarcoma. A. Chernoguz, E. C. Donovan, K. M. Crawford, A. E. Vandersall, J. S. Frischer; Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
6.3. Differential Gene Expression Analysis In Renal Cell Carcinoma As Compared To Pair Matched Patient Normal Tissues; A Novel Method In Identification Of New Diagnostic And Or Prognostic Markers In Renal Cell Carcinoma. T. L. Tello,4 F. J. Kim,1,2,3 S. Koul,1,2,3 H. Koul,1,2,3 Campagna,1,2,3 L. Khandrika1,2,3; 1Signal Transduction and Molecular Urology Laboratory, Division of Urology, UC Denver SOM, Aurora, CO; 2University of Colorado Cancer Center, Aurora, CO; 3Denver Health Medical Center, Denver, CO; 4 University of Colorado School of Medicine, Aurora, Colorado
6.4. A Monoclonal Antibody To Secreted Frizzle Related Protein-2 Inhibits Angiosarcoma Growth In Vivo. E. M. Fontenot, S. Siamakpour Reihani, E. C. Rossi, B. G. Bone, E. G. Hilliard, D. P. Ketelsen, C. M. Ross, C. Patterson, N. Klauber-DeMore; University of North Carolina At Chapel Hill, Chapel Hill, NC
6.5. Lack Of Th17 Cells Does Not Appear To have A Major Impact On Intestinal Tumorigenesis In MIN Mice. J. S. Gold,1,2,3 C. Pai,1 R. H. Prabhala,1,3 N. C. Munshi1,3; 1VA Boston Healthcare System, West Roxbury, MA; 2Brigham and Women’s Hospital, Boston, MA; 3Dana-Farber/Harvard Cancer Center, Boston, MA
6.6. Using Ultra High-Throughput Expression Analysis To Identify Variations In Pharmacogenomic Gene Expression Between Microsatellite-Unstable And Stable Colorectal Cancer Cells. M. N. Duldulao, W. Lee, W. Li, Z. Chen, J. Kim, J. Garcia-Aguilar; City of Hope - Department of General Oncologic Surgery, Duarte, CA
6.7. Clinical Characteristics Provide Clues to Colorectal Cancer Pathways: Is a KRAS or BRAF Mutation in Control? K. L. DeJulius, J. A. Sanchez, J. M. Church, M. F. Kalady; Cleveland Clinic, Cleveland, OH
6.8. Prognostic Impact of CXCR4 And CXCR7 Expression In Pancreatic Adenocarcinoma. F. Gebauer, M. Tachezy, H. Zander, J. R. Izbicki, J. Kaifi, M. Bockhorn; University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6.9. Molecular Profiling Of Synchronous And Metachronous Cancers Of The Pancreas Reveal Molecular Mimicry Between Samples From The Same Patient. J. R. Brody,1 J. Kline,2 V. Tolbott,1 E. P. Kennedy,1 H. Lavu,1 C. J. Yeo,1 A. K. Witkiewicz2; 1Thomas Jefferson University, Philadelphia, PA; 2 Thomas Jefferson University, Philadelphia, PA
6.10. Viral Immunization Induced CD8+ T Cell Response And Tumor Immunity Requires DC Expression of PAI-1. N. Yu, J. Kesterson, J. Vazzana, P. Shrikant, J. F. Gibbs; Roswell Park Cancer Institute, State University of New York At Buffalo, Buffalo, NY
6.11. Tumor-specific Expression And Alternative Splicing Of The COL6A3 Gene in Pancreatic Cancer. H. A. Arafat, M. Lazar, K. Salem, G. Chipitsyna, Q. Gong, M. Chu, C. J. Yeo; Thomas Jefferson University, Philadelphia, PA
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
5.10. An Urban-Rural Blight? Choledocholithiasis Presentation And Treatment. J. Shelton, K. Kummerow, S. Phillips, M. R. Griffin, M. D. Holzman, W. Nealon, C. Pinson, B. K. Poulose; Vanderbilt University Medical Center, Nashville, TN
5.11. Ethnicity And Insurance Status Affect Health Disparities In Patients With Gallstone Disease. J. J. Freeman, L. A. Boomer, A. Shenoy, D. Fursevich, A. Feliz; University of Nevada School of Medicine, Department of Surgery, Las Vegas, Nevada
5.12. The Impact of Diagnosis and Symptoms on Quality of Life of Patients with Colorectal Disease. What Matters Most? V. Advani, M. Thomas, J. Patton, M. L. Boehler, C. J. Schwind, J. Rakinic, I. Hassan; Southern Illinois University School of Medicine, Springfield, IL
5.13. The Role Of Minimal Invasive Surgery In Uncomplicated Diverticulitis. R. Pendlimari, M. Huebner, D. W. Larson, R. R. Cima; Mayo Clinic, Rochester, Minnesota
5.14. The Role Of Minimal Invasive Surgery In Complicated Diverticulitis. R. Pendlimari, M. Huebner, R. R. Cima, D. W. Larson; Mayo Clinic, Rochester, Minnesota
5.15. Factors That Affect Mortality Following Colectomy. D. A. Klima, R. A. Brintzenhoff, A. Neal, B. T. Heniford, G. Mostafa; Carolinas Laparoscopic and Advanced Surgery Program, Charlotte, NC
5.16. Incidence Of Bowel Obstruction Following Restorative Proctocolectomy: Increased After A Laparoscopic Approach? S. Dolejs, G. Kennedy, C. P. Heise; University of Wisconsin School of Medicine and Public Health, Madison, WI
5.17. Surgery For Constipation In Patients With Prior Spinal Cord Injury: The Department Of Veterans Affairs Experience. J. R. West, S. A. Mohiuddin, W. R. Hand, K. S. Virgo, E. M. Grossman, F. E. Johnson; Saint Louis University School of Medicine, Saint Louis, MO
ONCOLOGY 1: ONCOLOGY BASIC SCIENCE: PROGNOSTICS & THERAPEUTICS 6.1. Attempts To Enhance Gemcitabine Effects By Antiangiogenic Therapies In Pancreatic Cancer. N. Awasthi, M. A. Schwarz, R. E. Schwarz; University of Texas Southwestern Medical Center, Dallas, TX
6.2. Monotherapy with a selective EGFR inhibitor, gefitinib, fails to suppress vascular proliferation and tumor growth in a murine model of Ewing’s sarcoma. A. Chernoguz, E. C. Donovan, K. M. Crawford, A. E. Vandersall, J. S. Frischer; Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
6.3. Differential Gene Expression Analysis In Renal Cell Carcinoma As Compared To Pair Matched Patient Normal Tissues; A Novel Method In Identification Of New Diagnostic And Or Prognostic Markers In Renal Cell Carcinoma. T. L. Tello,4 F. J. Kim,1,2,3 S. Koul,1,2,3 H. Koul,1,2,3 Campagna,1,2,3 L. Khandrika1,2,3; 1Signal Transduction and Molecular Urology Laboratory, Division of Urology, UC Denver SOM, Aurora, CO; 2University of Colorado Cancer Center, Aurora, CO; 3Denver Health Medical Center, Denver, CO; 4 University of Colorado School of Medicine, Aurora, Colorado
6.4. A Monoclonal Antibody To Secreted Frizzle Related Protein-2 Inhibits Angiosarcoma Growth In Vivo. E. M. Fontenot, S. Siamakpour Reihani, E. C. Rossi, B. G. Bone, E. G. Hilliard, D. P. Ketelsen, C. M. Ross, C. Patterson, N. Klauber-DeMore; University of North Carolina At Chapel Hill, Chapel Hill, NC
6.5. Lack Of Th17 Cells Does Not Appear To have A Major Impact On Intestinal Tumorigenesis In MIN Mice. J. S. Gold,1,2,3 C. Pai,1 R. H. Prabhala,1,3 N. C. Munshi1,3; 1VA Boston Healthcare System, West Roxbury, MA; 2Brigham and Women’s Hospital, Boston, MA; 3Dana-Farber/Harvard Cancer Center, Boston, MA
6.6. Using Ultra High-Throughput Expression Analysis To Identify Variations In Pharmacogenomic Gene Expression Between Microsatellite-Unstable And Stable Colorectal Cancer Cells. M. N. Duldulao, W. Lee, W. Li, Z. Chen, J. Kim, J. Garcia-Aguilar; City of Hope - Department of General Oncologic Surgery, Duarte, CA
6.7. Clinical Characteristics Provide Clues to Colorectal Cancer Pathways: Is a KRAS or BRAF Mutation in Control? K. L. DeJulius, J. A. Sanchez, J. M. Church, M. F. Kalady; Cleveland Clinic, Cleveland, OH
6.8. Prognostic Impact of CXCR4 And CXCR7 Expression In Pancreatic Adenocarcinoma. F. Gebauer, M. Tachezy, H. Zander, J. R. Izbicki, J. Kaifi, M. Bockhorn; University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6.9. Molecular Profiling Of Synchronous And Metachronous Cancers Of The Pancreas Reveal Molecular Mimicry Between Samples From The Same Patient. J. R. Brody,1 J. Kline,2 V. Tolbott,1 E. P. Kennedy,1 H. Lavu,1 C. J. Yeo,1 A. K. Witkiewicz2; 1Thomas Jefferson University, Philadelphia, PA; 2 Thomas Jefferson University, Philadelphia, PA
6.10. Viral Immunization Induced CD8+ T Cell Response And Tumor Immunity Requires DC Expression of PAI-1. N. Yu, J. Kesterson, J. Vazzana, P. Shrikant, J. F. Gibbs; Roswell Park Cancer Institute, State University of New York At Buffalo, Buffalo, NY
6.11. Tumor-specific Expression And Alternative Splicing Of The COL6A3 Gene in Pancreatic Cancer. H. A. Arafat, M. Lazar, K. Salem, G. Chipitsyna, Q. Gong, M. Chu, C. J. Yeo; Thomas Jefferson University, Philadelphia, PA